15th European Molecular Imaging Meeting

Online Program Keyword Index

supported by:
Authors
Keywords
Chairs
To search for a specific ID please enter the hash sign followed by the ID number (e.g. #123).
 Day overview
Keyword Contributions
11c-methylation 113 
13c -labeled tracer 137 
13c mrs PS 23-03 
13c nmr PS 23-03 
18f PS 05-04 
18f-difluoromethylation 127 
18f-fdg PS 08-02 
18f-fdg pet 128 
18f-fdg pet/mri 100 
18f-fdg-pet PS 06-04 
18f-fluoronaphthol PS 21-07 
18f-flurolactate PS 08-02 
18f-fmiso PS 08-07 
18f-labelled tracers 115 
18f-naf 104 
18f-psma-11 100 
18f-sodium fluoride 135 
19f PS 08-04 107 
19f mri PS 08-04 PS 08-04 107 134 
19f mri inflammation imaging 105 
19f stem cell tracking 130 
19f-cest 134 
19f-icest 134 
19f-mri PS 08-04 126 130 
2-nitroimidazole 119 
2h fumarate PL 08-10-01 
2k1c 135 
31p magnetic resonance imaging 107 
31p magnetic resonance spectroscopy 107 
3d 137 
3d image registation 138 
3d imaging PS 20-05 
3d live imaging 118 
3d live tracking. 139 
3r 117 
5-ht1a receptors PS 23-02 
52-mn #92 
5d ct PS 02-02 
5xfad 128 
62zn PS 05-04 
68ga #40 131 
68ga-dkfz-psma-11 113 
68ga-dota-cdp1 131 
68gadfo 131 
89zr PS 09-07 
90y-dota-psma-d4 138 
99mtc-mibi 115 
99mtc-radiotracer 119 119 
[11c]ucb-j 129 
[18f]cf4 PS 08-03 
[18f]cinacalcet 113 
[18f]dpa-714 pet PS 21-03 
[18f]faza 120 
[18f]flt pet 120 
[18f]fluda 127 130 
[18f]fluoroform 113 
[18f]fluorothymidine 104 
[18f]frpg PS 08-07 
[18f]fspg PS 08-07 
[18f]ge180 PS 21-03 
[18f]psma-1007 100 
[68ga]-ubi 131 
a2ar 130 
abdominal aortic aneurysm PS 08-06 104 
abdominal wall recurrence 133 
absorbable sutures 104 
accurate measurement 115 
acetazolamide 127 
acetylcholine PS 23-02 
acini PS 08-06 
acoustic microscopy PS 08-06 
acquatic animal imaging 135 
acute cardiomyopathy induced by stress 130 
acute respiratory distress syndrome PS 21-02 
adenosine 130 
adenosine 2a receptor 102 
adenosine a2a receptor 127 
adept 134 
administration routes 135 
adoptive t cell therapy PS 23-05 
advanced microscopy 103 
affibody PS 23-05 
aging 138 
aif PS 08-03 
akt1 kinase 131 
alf-18 113 
alk5 PS 23-04 
allergic asthma 105 
alpha-synuclein 129 
als 128 
alternativ animal model PS 21-07 
alzheimer PS 08-03 
alzheimer disease model 102 
alzheimer model 102 
alzheimer' disease 129 
alzheimer's disease PS 01-06 PS 09-03 102 127 
alzheimer's mouse model 128 
alzheimer’s disease PS 09-03 
ambroxol 128 
amino acids 119 
amphipathic peptide 126 
amphotericin b PS 05-05 114 
amyloid PS 01-06 116 
amyloid beta 128 
amyloid plaques PS 09-03 
amyloid-beta PS 09-03 129 
anesthesia PS 23-02 PS 23-03 116 
aneuploidy PL 08-10-02 
angiogenesis 114 137 
angiography 129 
angiotensin ii 104 
animal PL 08-10-02 
animal model PS 01-06 PL 08-10-01 130 
animal study 138 
annexin a5 113 
anthracyclines 130 
anti-cancer agents 138 
anti-cancer drug 101 
antibiocs PS 05-07 
antibiotics PS 05-05 
antibody PS 05-07 PS 05-07 PL 08-10-03 100 132 
antibody labelling 136 
antibody modification PL 08-10-03 
anticancer 135 
antitumor metal complexes 106 134 
aortic dissection 104 
apoe-/- 104 
apoptosis PS 06-03 126 
aptamer PS 09-02 
aptamers 118 
arftificial intelligence PS 08-06 
arterial input function 103 
arterial tacs 135 
arthritis 117 
artifacts 137 
ascending aorta aneurysms 104 
asthma mouse model 116 
astrocytes 128 
asymmetric radiosynthesis 119 
atherosclerosis PS 23-04 PS 23-04 PS 08-04 #40 104 104 104 104 105 
atherosclerotic plaque 105 
atlas creation 103 
atlas registration 118 
au nanocluster 114 
auditory processing PS 08-03 
auger electrons 125 
auto-regressive model PS 08-06 
autoimmune-diseases 105 
automation 135 
autoradiography PS 01-06 
avb6 101 
axilla 100 
axr 137 
aza-bodipy 132 
azd2461 100 
azd3965 PS 08-02 
baboons PS 05-07 
background correction PS 08-06 
backscattering PL 08-10-03 
bacterial infection PS 05-07 
barrel PS 21-03 
barrett's oesophagus PS 09-07 
barrett’s esophagus PS 09-07 
basal cell carcinoma PL 08-10-02 
basal forebrain cholinergic system PS 23-02 
bbb PS 09-02 
beam hardening 116 
behavior 118 139 
bevacizumab PS 06-03 
bevacizumab-800cw PS 09-07 
biased agonist PS 23-02 
bicuspid aortic valve 104 
bimodal PS 08-02 
bimodal imaging 132 132 
bimodal mri/pet #92 
bimodality 106 106 
binding assay 118 
bioconjugation PS 05-04 
biodistribution 100 113 118 129 135 
bioimaging 113 114 114 136 
bioluminescence imaging 138 
biomarker PL 08-10-01 PS 05-03 133 137 
biomarkers 100 
biomaterials 135 
biotin 118 
birch pollen 105 
bispidine #92 
bladder segmentation 100 
bleomycin 116 
blood brain barrier 128 
blood flow PS 05-07 
blood half-life 113 
blood pressure radiotelemetry 132 
blood vessels permeability 137 
blood-brain barrier 129 
bodipy PS 06-05 
body imaging 137 
bold oscillations 103 
bone defect healing 135 
bone formation 105 
bone metastases PL 08-10-03 
bone metastasis PS 23-05 
bone model PS 09-07 
boron vectorization 101 
brain PS 05-07 PS 06-04 102 129 
brain atlas 103 127 
brain cancer 120 
brain imaging PS 05-04 
brain inflammation 103 
brain perfusion PS 05-07 
brain slice 103 
brain tumor PS 08-03 
brain tumors 113 
brain-targeted delivery system 113 
brainstate 127 
breast cancer PS 20-05 PS 23-05 PS 06-03 PL 08-10-02 100 117 
breast imaging 117 
breast tissue cancer 100 
brown adipose tissue PS 06-04 
bssfp 137 
burst suppression PS 23-02 
c. elegans 138 
calcification PS 05-04 PS 23-04 104 
calcifications PS 21-03 
calcium PS 23-04 PS 08-04 
calcium fluoreescence imaging 128 
calcium imaging PS 09-03 103 
calibration 118 
cancer PS 22-05 PS 05-03 PS 05-03 100 100 118 126 132 133 PS 24-02 
cancer cell spheroids 138 
cancer imaging PS 08-07 126 
cancer immunotherapy PS 05-03 
cancer surgery 138 
cancer targets PL 08-10-03 
cancer therapy 101 125 
candida albicans 131 
caps camera PS 23-07 
carbon monoxide #127 
carbon-11 113 119 
carbonic anhydrase ix PS 08-07 
carcinoma gall bladder 133 
cardiac 106 
cardiac imaging PS 21-02 
cardiac mri 133 
cardioavascular diseases PS 23-04 
cardiomyopathy PS 23-04 
cardiotoxicity 130 
cardiovascular 113 
cardiovascular disease 104 113 
cardiovascular diseases 133 
cardiovascular imaging 130 
carotid 104 
carotid artery 139 
carotid atherosclerosis 104 
cd11b 126 
cd4 t cells PS 05-03 
cd47 126 
cd8 PS 21-07 
cd80 PS 23-05 
cea 132 
cell death PS 06-03 
cell labelling 113 
cell therapy 106 128 
cell tracking PS 06-05 106 106 134 
cell-penetrating peptides PL 08-10-03 
cerebral blood flow 102 
cerebral ischemia PS 08-03 PS 09-03 
cerebral malaria PS 05-07 
cerebral metabolic glucose rate 103 
cerebral metabolism PS 23-03 
cerebrovascular PS 09-03 
cerenkov imaging PS 08-07 136 
cerenkov luminescence imaging 138 
cerenkov luminescence imaging (cli) 138 
cest PS 06-04 107 118 134 
cest quantification 118 
cest-mri 118 
chelation 135 
chelator-free radiolabelling 113 
chemical delivery system 113 
chemistry PS 05-04 
chemo-phototherapy 125 
chemokines PS 22-05 
chemoresistance 101 
chemosensitivity PL 08-10-02 
chemotherapeutics 138 
chemotherapy 101 
choline metabolism 133 
chronic pain 128 
chronic stage 128 
cisplatin PL 08-10-03 PL 08-10-02 125 
classification study 100 
clemastine 127 
click chemistry PL 08-10-03 PL 08-10-03 
click-chemistry PS 21-07 
clinical ct 116 
clinical isolates 130 
clinical translation PS 06-03 
clinical trial PS 23-07 PS 06-03 
clinical trials PS 09-07 132 
clustering 118 
cmr 130 
cochlea 103 
coincidence time resolution 115 
collagen based scaffold 129 
collagen organization 129 
colon cancer PS 08-02 118 120 
colorectal cancer PS 06-03 125 
colorectal cancer subtypes PS 05-03 
companion diagnostics PS 06-03 
compartment modelling 100 
compton camera PS 08-03 
computed tomography PS 05-05 PS 02-02 
computer-assisted image interpretation 118 
computer-assisted image processing 118 
cone trajectory PS 23-03 
confocal 120 
confocal fluorescence imaging 136 
congenital hyperinsulinism 133 
conjugated polymer nanoparticles 114 114 114 136 
conjugation 136 
connexin 127 
contrast agent PS 21-07 #303 100 105 106 107 114 
contrast agents PS 23-04 PS 08-04 101 116 116 116 134 
contrast enhanced ultrasound 125 
contrast media PS 21-02 
contrast-enhanced computer tomography 116 
contrast-enhanced ct 118 
contrast-enhanced ultrasound imaging PS 06-05 
copper trafficking PL 08-10-02 
copper-64 PL 08-10-02 
core-shell particles 136 
core-shell structures 106 
corioallantoic membrane 137 
coronary arteries PS 21-02 
cpg2 134 
crc mouse models PS 05-03 
crc stratification PS 05-03 
crispr/cas9 PL 08-10-01 
croconaine nanoparticles PS 08-03 
crohn's disease PS 08-03 
csf 127 127 
csf-1r PS 23-05 PS 21-03 
ct PS 01-06 PS 21-07 
ct filters 118 
ct imaging 116 
ct-fmt imaging 120 
cu-64 PL 08-10-03 
cuprizone 127 
curprizone 102 
cyanine dyes 113 
cyanine-graphene hybrids 136 
cyanines 114 
d2 receptor PS 23-02 127 
darpins 125 
data analysis PL 08-10-02 
data filtering 118 
data processing 118 
data quantification PS 08-06 
dce 118 
dce-mri 101 102 
ddnp PS 23-03 
deconvolution 118 
deep learning PS 08-06 118 
deep learning for ct PS 02-02 
default mode network PS 23-02 
demyelination 102 127 
dendrimer PL 08-10-03 
density 102 
depression 103 
desferrioxamine b 131 
desferrioxamine derivative PS 05-04 
desi PS 06-04 
deuterium PS 05-03 PS 06-04 
deuterium metabolic imaging PL 08-10-01 
deuterium mrs 133 
dfo* PS 09-07 
diabetes 118 
diagnosis 100 
differentiation 100 
diffusion 137 
dimeric pesin conjugates #84 
diphosphine-peptide 135 
disorder strength PL 08-10-03 
dispersion PS 08-03 
distraction osteogenesis 133 
dna damage 130 
dnp PS 06-04 
dominant follicle selection 137 
donepezil 127 128 
dopamine PL 08-10-01 
dopamine receptors expression changes PL 08-10-01 
dopaminergic system 127 
dosimetry 118 118 
dota 113 129 
down syndrome 104 128 
doxorubicin 125 129 
dp1tyb model 128 
dpa-714 PS 23-05 
dpet-ct 135 
dreadds PS 23-02 
drug delivery particles 138 
drug efficiency evaluation 138 
drug release PS 06-05 
drugs-lipiodol emulsions 106 
dti 102 128 
dual labeling PS 23-07 
dual-labeling #151 
dw-mri 120 
dwarf shrimp 118 138 139 
dwi 133 
dyes PS 09-02 
dynamic acquisition 120 
dynamic functional connectivity 102 
dynamic imaging PS 01-07 
dynamic pet 103 
dynamic-contrast-enhanced (dce) 107 
eae nhp 129 
early bladder tumour detection 100 
early detection PS 09-07 
egcg modulation 104 
egfr PS 23-05 100 119 
el4 137 
elastin-derived peptides PS 08-02 
electrophysiology PS 23-02 
elemental imaging PS 05-05 
embolization 104 
embryo 133 
emerging countries 104 
emi-137 PS 23-07 
emsot PS 06-03 
endocarditis 130 
endoscopy PS 23-07 PS 09-07 125 
enhanced permeability and retention (epr) effect 125 
enzyme activity 133 
enzyme imaging 133 
enzyme responsive mri contrast agent 134 
eosinophilic inflammation 105 
epcam 125 
epilepsy PS 08-03 PS 21-03 129 
episc 130 
epr 137 
epr effect PL 08-10-03 PL 08-10-02 
epr imaging 119 
epri in vivo 119 
esophageal cancer PS 09-07 125 
esophageal carcinoma PS 09-07 
ex vivo PS 23-07 129 
ex vivo biodistribution 105 
exchange 137 
exendin PS 09-07 133 
exfoliated graphene 136 
exosomes 103 129 
experimental autoimmune myocarditis 130 
extracellular lactate PS 06-04 
extracellular matrix 107 
f-18 135 
fap PS 21-07 
fast 3d epri 119 
fat correction 118 
fat deposition 138 
fatty acid 114 
fbp PS 01-03 
fcfm PS 05-07 
fdg 105 135 
fdg pet 130 133 
fdg pet/ct 133 
feline oral squamous cell carcinoma 125 
ferritin crystals 120 
ferrocene derivatives 101 
ferroptosis 120 
fexi 137 
fibril orientation 129 
fibroblast PS 21-07 
fibroblast activation protein PS 06-03 
fibrosis PS 23-04 139 
figure making PL 08-10-02 
fish 139 
fkbp12-ryr stabilizer 135 
flexivent 105 
fli PS 08-07 
flim 138 
flt-ct PS 05-05 
fluorescein 107 
fluorescein angiography 103 
fluorescence PS 23-07 PS 23-07 PS 06-05 100 104 114 114 125 132 136 
fluorescence imaging PS 04-05 
fluorescence guided surgery 132 
fluorescence image-guided surgery PS 05-03 132 
fluorescence imaging PS 05-05 PS 08-04 PS 08-02 138 
fluorescence life-time imaging 139 
fluorescence lifetime PS 23-07 
fluorescence microscopy PS 09-03 120 131 
fluorescence molecular tomography 139 
fluorescence monitoring 136 
fluorescence tomography 138 
fluorescence-guided surgery PS 23-07 PS 23-07 PS 08-02 
fluorescent dyes #84 
fluorescent guided surgery 132 
fluorescent imaging PL 08-10-02 
fluorescent molecular imaging 100 
fluorescent organic nanoparticles 114 
fluorescent platform 106 
fluorescent probes 114 136 
fluorescent probes for in vivo in real-time imaging 126 
fluorescent proteins 131 
fluorescent tracer 136 
fluorine magnetic resonance imaging 130 
fluorine-18 PL 08-10-03 119 127 
fluorogenic peptide 126 
fluorophores 132 
fmn 107 
fmri PS 23-02 PS 23-02 PS 08-03 PS 09-03 PS 09-03 103 118 127 
focused rf heating PS 23-03 
focussed ultrasound PS 09-02 
formaldehyde 136 
free flap monitoring 138 
fret 114 136 
fugene 106 
full-wave inversion 117 
fumarate PS 23-03 
functional connectivity PS 23-02 103 128 
functional imaging 117 
functional mri PS 08-03 137 
functional networks 102 
functional ultrasound 103 103 127 
functional ultrasound imaging PS 23-02 
fungal biofilm 114 
fungal infection 114 
fungal infection model 131 
fungal infections 131 
furimazine PS 08-02 
fus PS 21-03 
gadolinium 107 
gadolinium retention 107 
gadovist 107 
galectin-3 PS 05-03 101 
gallium-68 PS 05-04 PS 08-07 PS 08-02 119 128 131 
gallium‐68 131 
gangliosides PS 09-03 
gastrin-releasing peptide receptor 119 
gastrointestinal PS 05-05 105 
gbm PS 06-04 
gcamp 103 
gcp ii ligands PL 08-10-02 
gd(dota) nanoconstructs 134 
gd-aaztac17 134 
gd-conjugated capsules 134 
gdept PS 08-07 
genetic reporter systems 105 
gfr 135 
giant 134 
glial cells PS 01-06 
glioblastoma PS 23-05 120 125 126 133 
glioma PS 23-05 
glp-1 receptor PS 09-07 133 
glucose PS 23-03 
glucose metabolism 129 
glutamine PS 06-03 
glutathione 114 
glymphatic 127 127 
glymphatic system 102 
gold nanoclusters PS 05-05 
gold nanoparticles 101 118 125 138 
gold-shell nps 106 
good manufacturing practice 113 
graphene oxide 135 
group beta streptococcus (gbs) 131 
grpr 100 
grpr-antagonist 119 
gszs 107 
gvhd 105 
h69 xenograft 101 
halotag 129 
hcc PS 21-07 
head and neck cancer 125 
heart 130 
heart failure PS 23-04 
hemodynamics 133 
hemoglobin 133 
hepatitis 105 
heptamethinecyanine fluorescent dyes 136 
her2 PS 18-06 
her3 PS 18-06 
het-cam 119 
hetcam 119 
heterocyclic-substituted bodipy derivatives 136 
hgsoc PS 05-03 
high field 137 
high field mr 107 
high field mri 107 
high field strength 137 
high penetration depth PS 08-03 
high rate pet PS 21-02 
high resolution mri 137 
high temporal resolution 137 
high throughput imaging 118 
histology PS 08-02 
hne 136 
hnis 115 
hormones PS 08-03 
hounsfield units 118 
hpdo3a 107 
human carotid artery PS 23-04 
human skin 138 
humanized fab PS 05-03 101 
huntington's disease PL 08-10-01 102 
hybrid 139 
hybrid imaging PS 01-03 
hybrid pixel detector PS 08-03 
hydroxypyridinone 113 
hypercapnia 137 
hyperglycemia 128 
hyperoxia 137 
hyperpolarization PS 06-04 PS 06-04 PS 23-03 107 133 
hyperpolarized PS 23-03 
hyperpolarized 13c 133 137 
hyperpolarized mrsi 137 
hyperpolarized nmr 137 
hyperspectral PS 05-05 
hypertension 132 
hyperthermia 101 
hypoparathyroidism 118 
hypoxia PS 08-07 117 119 
ibca 134 
idiopathic lung diseases PS 05-05 
il-6 127 
illumination pattern PS 05-05 
image analysis 120 
image derive arterial input function 139 
image fusion PS 01-03 
image mass cytometry 120 
image processing PS 08-06 118 
image reconstruction PS 05-05 116 139 
image registration 118 
image-guided drug delivery PS 06-03 125 134 
imaging PS 05-03 PS 05-03 PS 23-03 PS 23-03 PL 08-10-03 106 117 125 131 
imaging biomarkers PS 06-03 PS 06-03 
imaging guided biodistribution 128 
imaging probes 134 136 
imaging processing PS 05-05 
imaging tumour cell death PL 08-10-01 
imatinib 104 
immnopet 126 
immune cell imaging 105 130 
immune checkpoint pathway 136 
immune inflammation 105 
immune-cell targeting PS 21-07 
immuno-oncology PS 22-02 
immuno-pet PS 05-04 PS 09-07 PL 08-10-03 #631 
immunocompetent models 126 
immunofluorescence #634 
immunology PS 09-02 
immunomodulation PS 21-03 
immunopet PS 05-03 PS 05-07 #151 
immunotherapy PS 20-05 PS 09-07 126 
implant 137 
implanted nmr microcoil PS 23-03 
imultaneous pet/ct-uui system PS 21-02 
in ovo 119 
in silico modeling 120 
in vitro 131 
in vivo PS 09-07 107 115 135 
in vivo bioluminescence 131 
in vivo cell tracking 138 
in vivo clearance 138 
in vivo confocal 131 
in vivo fluorescence imaging 138 138 
in vivo imaging PS 05-04 138 
in vivo micro-computed tomography 105 
in vivo micropet 105 
in vivo spectral unmixing 138 
in vivo two-photon 131 
in-loop 113 
in-vivo PS 08-04 132 
in-vivo imaging PS 21-02 
indium-111 106 
indocyanine green PS 06-05 118 132 132 
infection PS 05-07 PS 08-02 131 
infection imaging 130 131 131 
infectious diseases 131 
inflammation PS 06-04 PS 23-04 PS 23-04 PS 08-04 PS 21-07 PS 21-07 PS 09-02 102 105 105 130 136 138 
inflammation imaging 130 
inflammatory diseases 133 
innate immunity PS 21-07 
insulinoma PS 09-07 
integrin αvβ6 120 
integrins 101 
interness 107 
interrater reliability 100 
interstitial-illumination PS 09-02 
intra-operative imaging PS 05-03 PS 23-07 PS 23-07 132 
intranuclear PL 08-10-03 
intraoperative PS 23-07 PS 23-07 
intraoperative imaging PS 05-03 
intraperitoneal kainic acid rat model 102 
intraperitoneal tumor model 132 
intravital microscopy PS 23-05 PS 21-07 
intravital multiphoton microscopy PS 23-05 
invasive pulmonary aspergillosis 131 
inversion recovery 129 
iododifunisal 128 
ionizing radiation 130 
ipsc-nps 128 
ir800 dye 132 
irdye800cw conjugation 114 
iron metabolism 120 
iron oxide nanoparticles 107 120 
ischemia 129 
ischemia-reperfusion PS 21-03 
ischemic stroke 102 102 
ivis 138 
kem 118 
ketones PS 05-03 
kidney 137 
kinetic modeling PS 06-04 103 
kisspeptin 129 
kit-based infection imaging 131 
kp46 101 
l-cysteine PL 08-10-02 
l-dopa induced dyskinesia PS 23-02 
la-icp-ms PS 23-04 
label-free PS 23-04 
label-free molecular imaging PS 22-06 
labeling PS 06-05 126 
lanthanide complex 107 
lanthanide complexes 134 
laparoscopic cholecystectomy 133 
large stokes shift PS 06-05 
large vessel vasculitis 104 
laser speckle contrast imaging 132 
laser spectroscopy PS 05-05 
lc3 associated phagocytosis (lap) 131 
ldl 134 
led 117 
leucine 102 
life-threatening bleeding 104 
lifetime of fluorescence 138 
light sheet 138 
light sheet fluorescence microscopy 125 138 
light sheet microscopy 138 
light-triggered drug delivery #127 
line scanning PS 09-03 
lipid PS 23-04 
lipid metabolism 133 
lipids PS 08-03 PS 09-03 PL 08-10-02 
liposome labelling 113 
liposomes PS 09-02 134 135 
live cell confocal microscopy 101 
live-cell PS 22-06 
liver PS 09-02 138 138 
ln complexes 106 
localistion 129 
longitudinal in vivo micro-computed tomography 104 
lorentzian fitting 118 
low count imaging 115 
low dose imaging PS 01-07 
low molecular iron(iii)-complex-based contrast agents 134 
lps PS 08-03 105 
lsfm 120 138 138 
luciferin dose boost 131 
luminescence 106 
lung PS 08-06 
lung ct PS 21-02 
lung fibrosis 116 
lung imaging 116 139 
lung inflammation and fibrosis 105 
lung ventilation PS 08-03 
lymph node imaging 100 
lymph node staging PS 09-07 
lymphadenectomy PS 05-03 
macaca fascicularis 127 
machine learning PS 05-03 PS 08-07 PS 08-06 118 128 
maco 128 
macrophage PS 22-02 130 
macrophage mannose receptor 126 
macrophage mannose receptor (mmr) 126 
macrophage polarization 120 
macrophage profiling 126 
macrophages 126 126 130 
magnetic particle imaging 126 
magnetic resonance fingerprinting 137 
magnetic resonance imaging PS 19-03 PS 21-03 102 107 128 134 
magnetic resonance spectroscopy PS 06-04 128 
magnetization transfer contrast 134 
malaria PS 05-07 
maldi PS 08-03 133 
maldi-msi PS 23-04 100 
malignant melanoma PL 08-10-02 
manganese PS 23-04 #92 107 
manganese complexes 134 
manganese ferrite 106 
manganese-52 113 
mannose receptor PS 05-03 
maps PL 08-10-02 
mass spectrometry imaging PS 06-04 PS 09-03 103 
material decomposition 116 
mc1 receptor 114 
mct1 PS 08-02 
mcts 138 
mdsc 126 
mdsfr/sff spectroscopy 118 
mechanical force 120 
mechanical ventilation PS 08-06 
medical imaging PS 05-04 
medium-sized animal spect 115 
melanin 139 
melanocytic nevi PL 08-10-02 
melanoma PS 08-06 PL 08-10-03 100 114 
mesenchymal stem cells 129 
mesoporous silica nanoparticles PS 06-05 
metabolic PS 05-03 
metabolic changes 128 
metabolic disease 133 
metabolic imaging PL 08-10-01 133 138 
metabolic profiling PS 23-03 
metabolism PS 05-03 PS 06-04 PS 06-04 PS 06-04 PS 23-03 PS 23-03 133 PS 24-02 
metal airborne particles PS 05-05 
metal deposition 113 
metal doping 107 
metallomics PS 05-04 
metastases 120 
mhtt PL 08-10-01 
micro-ct PS 21-02 PL 08-10-03 116 116 
microalgae radiolabelling 135 
microbubbles PS 05-03 #127 
microct PS 01-06 116 118 118 139 
microct imaging 116 130 
microfluidics PS 08-04 113 
microglia 127 127 
micromechanics PS 08-06 
micropet PS 01-06 
micropet/ct PL 08-10-02 
microscopy PS 05-05 103 138 139 
microviscosity 138 
mid-infrared PS 22-06 
middle cerebral artery occlusion 102 
minflux PS 22-06 
mitochondria 130 
mitosis PL 08-10-02 
mitoxantrone PS 06-05 
mn2+ alternatives to gd3+ 107 
modeling 127 
models of sterile inflammation 105 
moderate severity stroke model 128 
molecular design PS 05-07 
molecular fluorescence guided imaging PS 23-07 
molecular imaging PS 08-07 100 104 104 114 115 117 118 
molecular modeling 127 
molecular pet imaging PS 18-06 
molecular rotors 138 
molecular vectors 118 
molecular-targeted PS 08-02 
monoclonal antibodies #631 
monocytes 105 
monte carlo 118 138 
monte carlo simulations 136 
morphometry 102 
motion compensation PS 02-02 
motion correction PS 21-02 139 
motor task PS 23-02 
mouse 103 
mouse model PS 05-07 129 129 
mpi 126 
mpo PS 21-07 
mr-angiography PS 05-07 
mri PS 01-06 #634 PS 05-07 PS 23-03 PS 23-04 PS 23-04 PS 08-04 PS 08-04 PS 21-07 PS 21-03 PS 21-03 PS 21-03 PS 09-07 #127 PS 09-03 100 101 101 101 101 102 106 106 118 118 119 119 127 127 127 128 129 129 129 133 133 133 134 134 134 134 134 134 134 139 
mri cas 107 
mri contrast agent 107 
mri contrast agents 106 125 134 
mri contrastagent 134 
mri probes PS 08-04 
mri signal amplification 134 
mri-guided therapy 101 
mri/pet dual probes 106 
mrs PS 08-04 PS 08-03 105 118 
mrs and mri PS 23-03 
mrsi 133 133 137 
msi PS 24-02 
msot PS 04-05 PS 08-03 117 
multi modality imaging 137 
multi-atlas 103 
multi-diameter single fiber spectroscopy / single fiber fluorescence (mdsfr/sff) PS 09-07 
multi-modal imaging #634 PS 08-03 
multi-pinhole spect 115 
multidrug resistance 120 
multimodal 106 
multimodal imaging PS 08-04 PS 08-03 #92 #84 PL 08-10-03 100 100 106 106 120 139 
multimodal microscopy #624 
multimodality 137 
multimodality imaging 101 
multiphoton microscopy 138 
multipinhole spect 115 115 115 
multiple sclerosis PS 05-04 102 129 
multiplexed imaging 114 
multiplexing PS 08-07 
multispectral PS 23-07 PS 09-07 
multispectral optoacoustic tomography PS 08-06 
myelin 102 129 
myocardial imaging 115 
myocardial infarction 105 130 130 130 
myocarditis 130 
myocardium PS 23-04 
nafld 133 133 
nano-carriers 101 
nano-radiomaterials #40 
nanobodies PL 08-10-03 126 126 
nanobody PS 05-03 PS 05-03 
nanoceramics 106 
nanodiamonds PS 06-05 100 
nanodroplets PS 06-05 
nanofluorides PS 08-04 
nanoluc complementation PS 08-02 
nanomedicine PS 06-03 PS 21-07 #40 125 
nanomedicines 125 
nanomicelles PS 08-04 
nanomotors PS 05-04 
nanoparticle PL 08-10-03 PL 08-10-02 
nanoparticle delivery 120 
nanoparticle labeling 106 
nanoparticles PS 08-04 106 106 119 135 
nanophosphor 136 
nanovesicles 114 
nash PS 21-07 105 
near infrared 114 114 138 
near infrared fluorescent molecular endoscopy PS 09-07 
near infrared optical tomography 139 
near-infrared fluorescence PS 05-03 132 132 
near-infrared fluorescence imaging 132 
near-infrared fluorescent dye 114 
near-infrared imaging 104 
near-infrared probe PS 06-05 
necrosis PS 06-03 
necrosis imaging 113 
neoadjuvant therapy PS 09-07 
neocardina 138 
network analysis 127 
network stabilization 128 
neuro-imaging 103 
neurobehavior 128 
neuroblastoma PS 09-07 
neurodegeneration 103 
neuroimaging PS 01-06 PS 06-04 102 102 103 
neuroinflammation PS 01-06 PS 09-03 127 128 
neuron cells 103 
neuronal cell cultures 128 
neuropeptides 129 
neuroprotection PS 21-03 128 
neuroradiology PS 01-06 
neurotensin PS 08-02 119 119 
neurovascular coupling PS 23-02 
neutrophils 105 
nevi 100 
new tracer 119 
nir-fluorescent tracers 114 
nir-ii contrast agent PS 08-07 
nirf PS 23-07 #151 
nitrogen-vacancy centers PS 06-05 
nitrosative stress 130 
nk1 receptors 128 
nmrd PS 08-04 
nodal metastasis PS 23-07 
non-absorbable sutures 104 
non-invasive PS 09-02 
non-invasive imaging PS 09-03 129 
non-linear imaging 138 
nonhuman primate 131 
novel theranostic probes 134 
nsclc 119 
ntr PS 08-07 
ntsr1 100 
nuclear imaging 105 132 
nuclear medicine PS 22-05 
nuclear morphology 118 
numerical simulation PS 05-05 
oatp PS 06-05 
obesity PS 21-03 
occupational exposure PS 05-05 
olinda 118 
oncocardiology 130 
oncology 101 
onolytic virus PS 08-02 
optical 139 
optical clearing 139 
optical control PS 05-07 
optical imaging PS 05-05 PS 08-02 #84 100 106 114 114 114 136 136 138 138 
optical imaging fluorophores 101 
optical imaging of infections 114 
optical imaging probe 132 
optical molecular imaging PS 08-02 
optical projection tomography 138 
optics PS 05-05 
optimization PS 05-05 
opto-acoustic 100 
optoacoustic PS 06-03 PS 08-03 PS 09-02 
optoacoustic bio-imaging PS 04-05 
optoacoustic imaging PS 23-05 104 133 
optoacoustic microscopy PS 22-06 
optoacoustic techniques 133 
optoacoustic tomography PS 06-03 103 117 129 
optoacoustics PS 08-07 PS 08-06 104 117 117 117 
optoacpustic imaging PS 09-02 
optogenetics PS 09-03 PS 09-03 
organic chemistry PS 05-04 
orthotopic glioblastoma model 120 
orthotopic mouse model 125 
orthotopic xenograft PS 05-03 
osem PS 01-03 
osimertinib 119 
osteoporosis 135 
ovalbumin 126 
ovarian cancer PL 08-10-03 PL 08-10-02 101 125 
ovarian transplantation 114 
oxidative stress 128 130 
oxidized low-density lipoprotein 104 
oxygen 133 
oxygen partial pressure measurment 138 
oxygenation 117 
oxygenation-sensitive mri 137 
p-selectin PS 21-07 PS 09-02 105 
p2y12 127 
p2y12 receptor 127 
p301s 128 
paclitaxel 134 
paediatric 118 
pain chronification 127 
palmitic acid 114 
pan-cancer 100 
pancreas PS 08-02 
pancreatic cancer PS 08-02 PS 08-02 PL 08-10-03 100 100 119 120 132 
pancreatic cyst neoplasm 100 
pancreatic ductal adenocarcinoma PS 06-03 
paracest 107 134 
parahydrogen PS 23-03 
parallel transmit rf coil arrays PS 23-03 
paramagnetism PS 06-05 
parametric mapping PS 19-03 
parathyroid gland 132 
parathyroid hyperplasia 113 
parkinson's disease PS 01-06 PS 23-02 129 
parkinson`s disease PL 08-10-01 
parp 100 135 
partial volume effect correction 139 
partial wave spectroscopy PL 08-10-03 
pathogenesis PS 05-07 
pathomechanism 130 
patient-derived xenograft PS 05-03 
patient-derived xenografts PS 23-05 
pd-l1 PS 18-06 PS 05-03 
pdac 119 133 137 
pdac cancer PL 08-10-03 
peg-spacer 119 
pept-in 131 
perfluorocarbons PS 23-04 
perfusion 113 117 132 
peripheral arterial disease 133 
peripheral vascular disease 133 
peristaltism 120 
permeability 137 
pertussis PS 05-07 
pertussis toxin 102 
perylene diimide PS 06-05 
pet PS 01-03 PS 01-06 PS 22-05 PS 22-02 PL 08-10-01 #634 PS 23-05 PS 05-03 PS 05-04 PS 05-04 PS 06-04 PS 06-03 PS 06-03 PS 23-04 PS 08-03 PS 08-03 PS 21-07 PS 21-07 PS 08-02 PS 09-07 PS 09-03 PL 08-10-03 PL 08-10-03 100 100 102 104 104 106 113 113 118 119 119 120 127 127 129 129 130 130 131 133 135 135 PS 24-02 
pet ct 135 
pet imaging PS 01-06 PL 08-10-01 PS 05-03 PS 05-04 PS 05-04 PS 23-02 PS 23-04 PS 21-07 PS 09-07 100 113 119 119 119 127 129 131 132 133 133 
pet imaging. PS 05-04 
pet infection imaging 131 
pet metallomics PL 08-10-02 
pet scan 103 
pet tracer 129 
pet-ct PS 05-07 PS 08-03 131 135 
pet-mr PS 21-02 
pet-mri PS 05-03 PS 21-03 129 
pet/ct PS 01-03 PS 01-07 PS 08-07 100 104 105 115 120 126 
pet/ct imaging PS 21-07 
pet/ct-imaging PS 05-03 
pet/fmri PS 23-02 
pet/mr PS 01-03 PS 21-02 118 
pet/mri PS 01-07 PS 08-03 PS 08-02 #303 105 106 106 115 
pet/spect PL 08-10-03 PL 08-10-03 
pfc-nanoemulsions 130 
pfcs 105 
ph imaging 107 118 137 
ph mapping 107 
ph sensor 134 134 
phantom PS 09-02 115 117 
phantoms 117 
pharmacokinetic 118 
pharmacokinetics PS 06-03 135 
pharmacology 103 
phase contrast imaging PS 21-02 
phase i 126 
phase mapping PS 21-03 
phase retrieved tomography 138 
phase-contrast 103 
phasecontrast PS 08-02 
phosphine 113 
phospolipids PS 08-04 
photo-cidnp 107 
photo/optoacoustic 126 
photoacoustic PS 06-05 PL 08-10-03 114 114 117 139 
photoacoustic imaging PS 06-05 PS 08-06 PS 09-02 117 136 
photoacoustics PS 09-02 104 117 117 133 
photocage 136 
photochemistry PS 05-04 
photocontrollable proteins PS 08-07 
photodynamic therapy PS 06-03 PS 21-07 125 125 
photoimmunotherapy PS 23-05 
photon counting PS 02-02 
photon-counting 116 
photon-counting micro-ct 116 
photopharmacology PS 05-07 
photoradiolabelling PS 05-04 
photosensitizer 125 
pituitary adenoma PS 23-07 
pla-nanoparticles 134 
placenta 133 
plaque burden 104 
plasmodium PS 05-07 
platform #151 
plga 138 
polarization second harmonic generation 100 
polarization sensitive shg 129 
polidentate chelators 113 
poly-histidine 104 
polychromatic 116 
polymer contrast agent 107 
polymer-in-oil material PS 09-02 
polymeric nanoparticles PS 08-04 
polymersomes 101 
polypept(o)ide stars 125 
polypyrrole nanoparticles 136 
porphyrins 113 
positon emission tomography 102 
positron emission tomography PS 01-06 PS 01-07 PS 08-07 #84 105 113 119 120 127 129 130 
postoperative hypoparathyroidism 132 
pre-clinical 128 
pre-clinical imaging 103 
pre-resonance PS 05-05 
precision medicine PS 23-05 125 
preclinical PS 01-07 115 118 118 120 133 133 
preclinical computed tomograpy 118 
preclinical imaging PS 05-05 PS 06-05 106 115 
preclinical mri 101 
preclinical pet PS 08-06 PS 21-02 103 
preclinical pet insert PS 21-02 
preclinical spect 115 115 
preclinical studies 127 
preclinical trials 125 
pretargeting PL 08-10-03 104 
primate PS 23-02 
probe chemistry 107 
product penetration 138 
prohance 107 
projections 138 
prostae & pancreas 107 
prostate cancer PS 23-07 PL 08-10-02 100 100 101 119 
proste cancer 100 
protein radiolabelling 126 
protein synthesis rate 102 
protein tau 128 
proteins PS 09-02 
proton therapy PS 06-05 
prrt 101 
psma PL 08-10-02 100 100 101 106 119 
pulmonary airways PS 21-02 
pulmonary arterial hypertension PS 23-04 
pulmonary fibrosis 116 
pulmonary hypertension 133 
pyclen derivatives 134 
q175 mouse model 102 
quantification PS 08-06 PS 08-02 115 118 
quantitation 132 
quantitative mri PS 19-03 102 137 
quantitative nanomechanics 120 
quantitative photoacoustic tomography 117 
quantitave 116 
quasi-periodic patterns 102 
rabbit 115 
radiation-induced nucleation theory PS 06-05 
radio-contrast agents 116 
radioactive labeling 113 
radiochemistry PS 05-04 PS 05-04 PS 08-07 135 135 
radiofluorination 113 
radiofrequency ablation PS 09-02 
radiolabeling 106 119 
radiometal 113 
radiomics 104 118 118 
radionuclide PS 23-07 
radionuclide therapy 101 101 
radiosynthesis 135 
radiotoxicity 125 
radiotracer PS 05-07 127 135 
radiotracers PS 01-06 
raman mapping 126 
raman spectroscopy 138 
range verification PS 06-05 
rasp PS 09-02 
rat PS 23-02 PS 08-03 129 
ratiometric mri method 107 
ratiometry PS 08-04 
rats 118 
real-time mri PS 19-03 
recombinant proteins 104 
reconstruction 118 
reconstruction algorithm 115 
recovery 102 
redox-sensitive 114 
regularization PS 05-05 
remote ischemic conditioning PS 21-03 
remyelination 127 
renal PS 23-03 
repeated social defeat 103 
reporter gene 129 
resistance PL 08-10-03 
resolution modeling PS 01-03 
respiratory system 104 
response to therapy PS 06-03 
responsive agents 107 
responsive contrast agent 107 
resting state PS 23-02 PS 08-03 103 103 127 
resting state fmri PS 23-02 PS 08-03 128 
resting state functional mri 102 
retention 107 
retina 129 
reward system 127 
rf coil design 137 
rhenium 113 
rheumatoid arthritis PS 21-07 
rhodobacter 126 
riboflavin 125 
rnaseq PL 08-10-02 
rodent 103 
ros PS 21-07 113 
rotenone mouse model of parkinson's disease 102 
rs-fmri 127 
rsfmri 102 
s. aureus 130 131 
safir PS 21-02 
sah 128 
sample collection PL 08-10-02 
sarcoma PS 23-07 
scaffold characterization 129 
scan protocol optimization 100 
scinitgraphic 135 
scintillator crystal 115 
segmentation 103 118 
selective targeting 106 
semiquantification PS 08-06 
sensory stimulation 103 
serotonin transporter PS 23-02 
shift reagent PS 06-04 
short term modulation PS 23-02 
shortwave infrared fluorescence PS 05-05 
siderophore 131 
siderophores 131 131 
sigma-1 receptor 120 
silica nanoparticles 106 
silicosis mouse model 105 
simulation 138 
simulations 118 
simultaneous 3pef and 2pef microscopy 103 
simultaneous pet/ct-uui system 139 
simultaneous pet/mri 106 
single molecule localization PS 22-06 
single molecule tracking PS 22-06 
single voxel 1h spectroscopy 128 
single-domain antibody 132 
site-specific PS 05-03 #151 
site-specific bioconjugation 104 
skeletal muscle recovery 118 
skin cancer PL 08-10-02 
sliding window analysis 102 
slow waves PS 09-03 PS 09-03 
small animal PS 01-07 
small animal mri 137 
small animal pet PS 21-02 
small molecule donor 136 
small molecule targeting moieties 114 
small molecules 105 
small-animal imaging 115 
small-animal spect 115 
smart contrast agent 107 
smart probes 107 
smartphone ophthalmoscope 103 
smartprobe 136 
smartprobes 114 
sodium PS 23-03 
somatostatin receptor PS 23-07 
sonopermeation 125 
sonoporation 101 
spatial statistics 120 
spatial transcriptomics 103 
spect PS 01-03 PS 08-07 106 106 113 113 135 
spect/ct PS 01-03 PS 08-03 105 118 120 
spect/ct imaging 135 135 
spect/mri PS 05-07 
spectiq phantom 115 
spectroscopic ct PS 08-03 
spectroscopy PS 06-04 PS 09-02 
speed-of-sound 117 
spheroids PL 08-10-03 PL 08-10-03 101 
spill-in effect PS 08-06 
spim 138 138 
spinal cord injury 102 129 
spion 106 
spions 106 
spline 118 
spm PS 08-06 
spondyloarthritis 105 
stability 107 
standardisation 117 
staphylococcus aureus PS 05-07 
stem cells PS 06-05 106 106 
stent graft infections 131 
stimulated raman scattering PS 05-05 
strain PS 08-06 
stroke PS 06-04 PS 21-03 PS 21-03 102 103 128 128 
stroke model PS 21-03 
stroke-induced hyperconnectivity 128 
structure-activity relationships 135 
subarachnoid haemorraghe 128 
subcutaneous tumor xenografts 139 
sultone 119 
super resolution PS 06-05 
super resolution in cardiac pet PS 21-02 
super resolution optical microscopy PS 22-06 
super-resolution microscopy 131 
superparamagnetic nanoparticles 106 
superresolution PS 09-03 
supra molecular probes 134 
surgical margin assessment 138 
susceptibility-weighted imaging PS 21-03 
sv2a 127 129 
swir imaging PS 08-07 
synaptic density 102 129 
synaptique density 127 
synchrotron imaging 116 
synchrotron radiation PS 21-02 PS 21-02 
synchrotron xrf PS 23-04 
synthesis PS 06-05 
synthesis and characterization 136 
synuclein 116 
system xc- PS 08-07 
t-cell 105 
t-cell lymphoma PS 06-04 
t1 contrast 107 
t1-mri #40 
t1-weighted 3d mr 128 
takotsubo syndrome 130 
tam 126 
target-to-background ratio (tbr) PS 08-06 
targeted 106 
targeted alpha-particle therapy 101 
targeted drug delivery PS 23-03 125 
targeted hyperthermia PS 23-03 
targeted imaging 135 
targeted nanobubbles 114 
targeting PS 08-04 106 134 
tau PS 01-06 PS 21-03 
tc-99m 130 
tca cycle 137 
technetium 126 
technetium-99 113 
technetium-99m 135 
technical validation PS 09-02 
temporal lobe epilepsy 102 
tetrazoles PS 05-04 
tgf-beta PS 18-06 
thalamus 127 
thallium 135 
thallium-201 125 
theranostic 125 
theranostic agents 106 
theranostic probes 101 
theranostics PS 22-05 PS 05-07 PL 08-10-03 106 125 125 
therapeutic biologicals #631 
therapy 128 
therapy monitoring PS 09-02 
thermogenic activator PS 06-04 
thermosensitive liposome 101 
third harmonic generation 100 
third harmonic generation (thg) 138 
thn201 127 
thp 135 
thrombectomy PS 21-03 
thrombosis PS 23-04 
thyroid cancer PS 05-03 PS 23-07 101 
thyroid surgery 118 
time-lapsed tomography PS 01-07 
time-resolved near-infrared spectroscopy 138 
tissue distribution 115 
tissue implants PS 08-04 
tissue-mimicking material PS 09-02 
tof-kem 118 
tof-pet 115 118 
tof-sims 138 
tolcapone 128 
toll-like receptors 102 
tomographic microscopy 138 
tomography PS 08-02 117 117 
translational 118 132 
translational imaging PS 21-03 
translational research 116 
transthyretin 128 
transverse electron microscopy 106 
treatment response PS 06-03 
trifluoromethylation 135 
trimodal nanosystems 106 
tris (8-hydroxyquinolinato) gallium (iii) 101 
tsne PS 08-03 
tspo PS 08-06 130 132 
tumor 126 
tumor acidosis #303 107 
tumor imaging 119 
tumor invasion PS 23-05 
tumor markers 132 
tumor microenviroment 139 
tumor microenvironment PS 23-05 PS 23-05 120 125 
tumor microenvironment heterogeneity 120 
tumor microenvironment ph PS 08-07 
tumor profil 120 
tumor targeting PS 06-03 
tumor-associated macrophages 126 
tumor-associated-macrophage 126 
tumor-homing phagocytes PS 21-07 
tumors PS 05-03 
tumour PS 23-03 PL 08-10-02 118 
tumour micro environment 120 
tumour microenvironemnt PS 06-04 
tumour vascularisation PL 08-10-02 
tuning photophysical properties 136 
turbid media PS 05-05 
u-spect5 e-class 115 115 
ucb-h 102 
ultra-high field mri PS 23-03 
ultrafast imaging PS 09-03 
ultrafast ultrasound 120 
ultrafast ultrasound imaging 130 
ultrasmall nanoprobes 106 
ultrasound #634 PS 05-03 #127 PS 09-03 PS 09-02 PS 09-02 101 117 117 
ultrasound image processing 100 
ultrasound imaging 132 
ultrasound molecular imaging PS 21-07 PS 09-02 
ultrasound therapy 101 
ultrasound-guided injection PL 08-10-03 
ultrasounds PS 21-03 PL 08-10-03 
upar 100 
upconversion 106 
uptake 101 
usmb 125 
uspio PS 09-07 
validation 118 
vanco-800cw 114 
vap-1 130 
vascular PS 21-03 
vascular disorder PS 05-05 
vascular impairment 102 
vascular permeability 134 
vasculature PS 23-05 
vasoreactivity 137 
vessels PL 08-10-02 
vevolazr-x PL 08-10-03 125 
vhh PS 08-07 
viability PS 23-04 
voxel-by-voxel analysis PS 08-03 
water-soluble aza-bodipy PS 08-07 
western diet PS 08-03 
white matter 127 
white matter hyperintensities 118 
whole body PS 01-07 
whole-body 3d 137 
whooping cough PS 05-07 
x-nuclei 137 
x-ray PS 08-02 
x-ray computed tomography PS 21-02 
x-ray energy 118 
x-ray imaging 118 
x-ray tomography 103 116 
xenograft 119 
xlf 116 
xten 113 
zebrafish PS 21-02 116 
zinc mapping 134 
zinc sensors 107 
zirconium-89 PS 05-04 106 #631 
zirconium[89] PS 05-07 
zymonic acid 137 
µct 105 133 
µpet 133 
µspect 133 
α1-microglobulin 101 
α4β2 nicotinic acetylcholine receptor 102 
fluorescence microscopy 106